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Introduction
Patients with acute exacerbations of chronic obstructive
pulmonary disease (AECOPD) visiting the EDs are often
hospitalized. Assessing the severity of AECOPD is man-
datory to guide decisions of orientation as well as inten-
sity of monitoring treatment and follow-up during and
after the acute episode. Despite several published scores
for predicting outcome in AECOPD a simple and clini-
cal prediction model is still lacking for patients admitted
to the ICU.
Objectives
In our ICU the past years standard mortality rate of
AECOPD exceeded the national standard. Therefore we
studied this cohort of patients from January 2011 until
March 2014 retrospectively aiming to assess the validity of
several known predictive scoring models ( e.g. BAP-65
score, DECAF-score, eMRCD score and CAOS- score) and
to find possible factors that could also be associated with
poor outcome of these patients treated in the ICU [1].
Methods
All data from patients admitted to the ICU form January
2011 until March 2014 were studied using medical files
and Mediscore, a national database of all patients
admitted in ICUs in the Netherlands. To evaluate differ-
ence in survivors and non-survivors of AECOPD we
used chi square test and non-parametric tests. Area
under the receiver operating characteristic-ROC analysis
was used to assess the discriminative capacity of several
prediction models.
Results
There were 163 patients with mean Apache 4 score 57.2
(16.6), Apache 2 score 17.4(5.1). N = 115 survivors and n
= 48 non-survivors. Mean age 67, sd9.3. BMI 24.5 (sd 5.1).
58% were classified as GOLD IV and 37% used long-term
oxygen therapy. 50% of patients were limited by the dis-
ease. 20% were “bed-chair” mobilisers and 30% was house-
bound. Coronary disease was a known co-morbidity in
22.7% with heart failure in 11%. 24.5% of patients was
diagnosed with pneumonia at admission.
We found no significant difference between survivors
and non-survivors in demographic data, severity of
COPD, mobility or co-morbidities. Only CAOS score
and Apache 4 were significant different in both groups
with a poor discriminative value in predicting in hospi-
tal- and 180-day mortality (AUROC 0.644 and 0.652
resp.). See Table 1:
Conclusions
In patients with AECOPD admitted to our ICU for
further treatment the known prediction models have
poor discriminative capacity in predicting in hospital as
well as 180- day mortality. Further research to find pre-
dictive scores for AECOPD is mandatory.
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CAOS 0.644 0.580 n.s.
Apache 4 0.652 0.577 n.s.
BAP-65 0.543 0.477 n.s.
DECAF 0.523 0.522 n.s.
eMRCD 0.555 0.563 n.s.
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